PD 135390

PD 135390 Suppliers list
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
PD 135390 Basic information
Product Name:PD 135390
Synonyms:PD 135390;Glycinamide, N-(4-morpholinylsulfonyl)phenylalanyl-N-[4-[(butylamino)carbonyl]-1-(cyclohexylmethyl)-2-hydroxy-5-methylhexyl]-2-(2-propenylthio)- (9CI);(Rac)-PD 135390
CAS:150351-31-8
MF:C37H61N5O7S2
MW:752.04
EINECS:
Product Categories:
Mol File:150351-31-8.mol
PD 135390 Structure
PD 135390 Chemical Properties
density 1.21±0.1 g/cm3(Predicted)
pka10.88±0.20(Predicted)
Safety Information
MSDS Information
PD 135390 Usage And Synthesis
DescriptionPD 135390 is a novel HIV-1 protease inhibitors identified by rational selection. The human immunodeficiency virus (HIV-1), associated with the AIDS (acquired immunodeficiency syndrome) epidemic, encodes an aspartyl protease that is essential for polyprotein processing in the virus (Navia et al., 1989). It has been demonstrated that inactivation of the protease either catalytically or by an inhibitor prevents infectious virion formation (Kohl et al., 1988; Darke et al., 1989). The acquired knowledge of key molecular interactions occurring between inhibitors and aspartyl proteases, as well as the structural similarities between HIV-1 protease and human renin was used to rationally select candidates for HIV-1 screening from the pool of analogs designed as renin inhibitors. A minimal number of chosen compounds were tested in an HIV-1 protease assay system. Two structurally novel peptides emerged as potent enzymatic protease inhibitors. This study highlights the selection process and characterizes the antiviral properties of the two novel analogs.
Uses(Rac)-PD 135390 is a dipeptide and an HIV-1 protease inhibitor with an IC50 of 2 nM. (Rac)-PD 135390 can be utilized in antiviral research[1].
References[1] Humblet CC, et al. Characterization of two structurally novel HIV-1 protease inhibitors identified by rational selection. Antiviral Res. 1993 May;21(1):73-84. DOI:10.1016/0166-3542(93)90068-t
PD 135390 Preparation Products And Raw materials
Tag:PD 135390(150351-31-8) Related Product Information
Theaflavin 3,3′-digallate Dynasore Glycyrrhizic acid PF429242 dihydrochloride (-)-Epicatechin gallate Mangostin